St. Jude Medical, Inc. (NYSE:STJ) announced it has been awarded a patent from the U.S. Patent and Trademark Office conducive to treating depression using neurostimulation psychotherapy in an arena of the intellectual known as Brodmann Area 25.
Brodmann Close 25 is a organization within the subcollosal gyrus region of the brain. It is the focus of the St. Jude Medical BROADEN(TM) (BROdmann Neighbourhood 25 DEep brain Neuromodulation) muse about, which is evaluating whether deep sense stimulation (DBS) cure can workers people who suffer from major depressive disorder, a dire form of impression. This study is being conducted under a U.S. Scoff and Dose Administration (FDA) Investigational Device Exemption (IDE), which was announced in February 2008.
“This patent is a cornerstone in developing our passage to lost brain stimulation fitted depression, which is the leading belief of disability in the U.S. come up to b become illnesses,” said Chris Chavez, president of St. Jude Medical’s ANS Division. “The BROADEN study provides hope respecting a sober new psychotherapy to the millions of patients still seeking treatment for their critical concavity.”
On April 4, St. Jude Medical enrolled the first unfailing, a woman from Chicago, in the BROADEN study. The patient will be implanted with the Libra(R) Deep Thought Stimulation Methodology, an investigational device, at Alexian Brothers Behavioral Condition Sanatorium in Chicago.
“There is a tremendous need for inquire into in the area of major depressive disorder, distinctively among those who have weak other treatment options,” said Anthony D’Agostino, M.D., medical director of Alexian Brothers Behavioral Health Hospital and the prima donna investigator at the writing-room site. “We hope that our participation in the study inclination combine to the centre of research previously conducted for patients hardship from dent and, if possible, shed some clarification on what type of patient is most likely to benefit.”
Co-investigators at Alexian Brothers Behavioral Health Infirmary are psychiatrists Greg Teas, M.D., Slash Lerman, M.D. and neurosurgeon Konstantin Slavin, M.D.
The BROADEN inspect is a controlled, multi-install, blinded, clinical enquiry of deeply brain stimulation in the U.S. It will build upon the pioneering depression work conducted at the University of Toronto by a research team led by neurologist Helen S. Mayberg, M.D. (now with Emory University School of Medicine) and neurosurgeon Andres Lozano, M.D.
The Libra Deep Brain Stimulation System, which is being evaluated in this sanctum sanctorum, is designed to deliver mild pulses of common from a device implanted next-door the collarbone and connected to small electrical leads placed at specific targets in the brain.
In the U.S., more than 21 million adults suffer from some kind of depressive disorder, according to the National Alliance of Mental Health. Since barely approximately 80 percent can be effectively treated with currently available therapies, approaching 4 million matured Americans spend with despair that does not respond to medications, psychotherapy or electroconvulsive therapy. The World Health Organization estimates that depression affects thither 121 million people worldwide.
For more news apropos this study, call toll-free 866-787-4332 or visit http://www.BROADENstudy.com.
Here St. Jude Medical
St. Jude Medical is dedicated to making life excel into cardiac, neurological and chronic cramp patients worldwide because of excellence in medical device technology and services. The Public limited company has five major cynosure clear areas that group: cardiac rhythm management, atrial fibrillation, cardiac surgery, cardiology and neuromodulation. Headquartered in St. Paul, Minn., St. Jude Medical employs nearly 12,000 people worldwide. For more word, amuse affect http://www.sjm.com.
Approximately the ANS Partition of St. Jude Medical
The ANS Division (Advanced Neuromodulation Systems) became a part of St. Jude Medical in 2005. The ANS Division is an innovative technology leader dedicated to the intentions, maturation, manufacturing and marketing of implantable neuromodulation systems to improve the value of life for the sake people hardship from disabling chronic woe and other nervous system disorders (http://www.ans-medical.com
Apropos Alexian Brothers Behavioral Health Hospital
Alexian Brothers Behavioral Health Hospital, located in Hoffman Estates, Immoral., offers comprehensive behavioral health services, from prevention and early intervention to treatment and aftercare. Their group is to help individuals of all ages learn down-to-earth ways to manage mental health and quintessence abuse problems. Alexian Brothers Behavioral Haleness Hospital has earned the Joint Commission’s Gold Seal of Approval for Disease-Specific Certification in Depression, Chemical Dependency, Eating Disorders, and Self-Impairment. Alexian Brothers Behavioral Medical centre is influence of the Alexian Brothers Health Hospital Network, a diversified Catholic healthcare system based in Arlington Heights, Ill., and comprised of four hospitals which help the nearly two million residents of Chicago’s northwest suburbs (http://www.alexianbrothershealth.org).
Forward-Looking Statements
This scoop emancipate contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 that concern risks and uncertainties. Such forward-looking-looking statements include the expectations, plans and prospects for the Company, including potential clinical successes, anticipated regulatory approvals and future merchandise launches, and projected revenues, margins, earnings, and customer base shares. The statements made by the Gathering are based upon management’s current expectations and are contingent on expose to unfailing risks and uncertainties that could agent actual results to differ significantly from those described in the forward-looking statements. These risks and uncertainties tabulate market conditions and other factors beyond the Company’s dominance and the jeopardy factors and other cautionary statements described in the Company’s filings with the SEC, including those described in the Company’s Annual Report on Form 10-K filed on February 27, 2008 (see Detail 1A on pages 13-20, and period 20 of Demonstrate 13 to the Company’s Comprise 10-K). The Company does not resolve to update these statements and undertakes no part to any person to provide any such update junior to any circumstance.
St. Jude Medical
Leave a comment»